{"SPADE_N_13813": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13813", "Peptide Name": "Palustrin-2LTb (XXU; 1S=S, UCSS1a; natural AMPs; frog, amphibians, animals; BBMm)", "Source": "skin secretion, the Kuatun frog,Hylarana latouchii, China, Asia", "Family": "Not found", "Gene": "Not found", "Sequence": "SLWENFKNAGKKFILNILDKIRCRVAGGCRT", "Sequence Length": 31, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3552.18, "PI": 10.06, "Hydrophobicity": -0.22, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Wanchen Zou, Yingqi Zhang, Mei Zhou, Xiaoling Chen, Chengbang Ma, Tao Wang, Yangyang Jiang,Tianbao Chen, ChrisShaw, Lei Wang 2022", "Reference": "Computational and Structural Biotechnology Journal. Available online 12 November 2022", "Title": "Exploring the active core of a novel antimicrobial peptide, palustrin-2LTb, from the Kuatun frog, Hylarana latouchii, using a bioinformatics-directed approach"}], "Frequent Amino Acids": "KGI", "Absent Amino Acids": "HMOPQUY", "Basic Residues": 7, "Acidic Residues": 2, "Hydrophobic Residues": 12, "Polar Residues": 17, "Positive Residues": 7, "Negative Residues": 2, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (96.77%) toPalustrin-2LTaGRAVY: -0.222; Mol Wt: 3552.223; mol formula: C158H264N45O41S2; mol ex coeff: 5675 (Cys paired).Activity: Activity tested against Gram-positive bacteria S. aureus ATCC 6538 or MRSA NCTC 1249 (MIC 32 uM), E. faecium NCTC 12697 (MIC 16 uM), Gram-negative bacteria E. coli ATCC 8739 (MIC 8 uM), K. pneumoniae ATCC 43816 (MIC 8 uM), P. aeruginosa ATCC 9027 (MIC 16 uM),  A. baumannii ATCC BAA 747 (MIC 32 uM), and yeast, C.albicans ATCC 10231 (MIC >128 uM).Activity robustness: its activity was not compromised by salts and 10% FBS (Fetal Bovine Serum).MOA: membrane permeabilization.SAR: the peptide become most active (MIC 2-8 uM against bacteria) when the Rana box was removed.Toxicity: horse erythrocytes (2%): HC50=102.4 uM.Structure: Helical in 50% TFE or DPPG-containing vesicles.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_25077", "Similarity": 1.0, "Sequence": "SLWENFKNAGKKFILNILDKIRCRVAGGCR"}, {"SPADE_ID": "SPADE_UN_25078", "Similarity": 1.0, "Sequence": "SLWENFKNAGKKFILNILDKIR"}, {"SPADE_ID": "SPADE_UN_25079", "Similarity": 1.0, "Sequence": "SLWENFKNAGKKFILNILDK"}]}}}